Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Invested Capital (2016 - 2018)

Historic Return on Invested Capital for China Pharma Holdings (CPHI) over the last 10 years, with Q4 2018 value amounting to 0.29%.

  • China Pharma Holdings' Return on Invested Capital rose 800.0% to 0.29% in Q4 2018 from the same period last year, while for Dec 2018 it was 0.29%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.27% for FY2018, which is 900.0% up from last year.
  • China Pharma Holdings' Return on Invested Capital amounted to 0.29% in Q4 2018, which was up 800.0% from 0.41% recorded in Q3 2018.
  • China Pharma Holdings' 5-year Return on Invested Capital high stood at 0.07% for Q4 2015, and its period low was 0.44% during Q1 2015.
  • Moreover, its 5-year median value for Return on Invested Capital was 0.25% (2015), whereas its average is 0.25%.
  • Within the past 5 years, the most significant YoY rise in China Pharma Holdings' Return on Invested Capital was 3000bps (2015), while the steepest drop was -3100bps (2015).
  • Quarter analysis of 5 years shows China Pharma Holdings' Return on Invested Capital stood at 0.37% in 2014, then soared by 82bps to 0.07% in 2015, then crashed by -103bps to 0.13% in 2016, then crashed by -175bps to 0.37% in 2017, then increased by 21bps to 0.29% in 2018.
  • Its Return on Invested Capital stands at 0.29% for Q4 2018, versus 0.41% for Q3 2018 and 0.38% for Q2 2018.